Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity. | Biochem Pharmacol | 2022 | 35872325 | PubTator, text mining | PubMed |
| Pharmacokinetics of isoniazid and rifapentine in young pediatric patients with latent tuberculosis infection. | Int J Infect Dis | 2022 | 35868608 | PubTator, text mining | PubMed |
| Transcriptomic atlas of GNAT family members in pulmonary epithelia under pathological conditions using single-cell and bulk cell sequencing. | Clin Transl Med | 2022 | 35858249 | PubTator, text mining | PubMed |
| Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models. | Eur J Clin Pharmacol | 2022 | 35852584 | PubTator, text mining | PubMed |
| Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing. | Front Pharmacol | 2022 | 35846994 | PubTator, text mining | PubMed |
| Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients. | Front Genet | 2022 | 35836575 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV. | Clinicoecon Outcomes Res | 2022 | 35832304 | PubTator, text mining | PubMed |
| Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers. | Front Oncol | 2022 | 35814391 | PubTator, text mining | PubMed |
| Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing. | Front Pharmacol | 2022 | 35814236 | PubTator, text mining | PubMed |
| Melatonin and the Brain-Heart Crosstalk in Neurocritically Ill Patients-From Molecular Action to Clinical Practice. | Int J Mol Sci | 2022 | 35806098 | PubTator, text mining | PubMed |
| Abstracts from "Chronic viral infection and cancer, openings for vaccines" virtual symposium of the TechVac network. | Infect Agent Cancer | 2022 | 35804458 | PubTator, text mining | PubMed |
| Analysis of pharmacogenomic very important pharmacogenomic variants: CYP3A5, ACE, PTGS2 and NAT2 genes in Chinese Bai population. | Per Med | 2022 | 35801384 | PubTator, text mining | PubMed |
| The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review. | Pharmgenomics Pers Med | 2022 | 35795337 | PubTator, text mining | PubMed |
| Trends in insulin resistance: insights into mechanisms and therapeutic strategy. | Signal Transduct Target Ther | 2022 | 35794109 | PubTator, text mining | PubMed |
| Bilateral congenital membranous cataracts due to Glucosaminyl (N-Acetyl) Transferase 2 (GCNT2) mutation: Life-saving genetic analysis. | Indian J Ophthalmol | 2022 | 35791175 | PubTator, text mining | PubMed |
| Clinical standards for drug-susceptible pulmonary TB. | Int J Tuberc Lung Dis | 2022 | 35768923 | PubTator, text mining | PubMed |
| Molecular and Functional Characterization of N-Acetyltransferases in Common Marmosets and Pigs. | Drug Metab Dispos | 2022 | 35768074 | PubTator, text mining | PubMed |
| Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer. | Sci Total Environ | 2022 | 35764155 | PubTator, text mining | PubMed |
| Diet quality, common genetic polymorphisms, and bladder cancer risk in a New England population-based study. | Eur J Nutr | 2022 | 35759030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=22